Table 3.

Cox regression analysis for all-cause death

Univariable		Multivariable
HR (95% CI)	P value	HR (95% CI)	P value
Age	1.089 (1.080–1.099)	<0.001	1.074 (1.060–1.088)	<0.001
Female	1.432 (1.295–1.583)	<0.001	1.312 (1.025–1.681)	0.031
BMI	0.823 (0.789–0.848)	<0.001	0.924 (0.893–0.957)	<0.001
STEMI	1.157 (1.049–1.276)	0.004	0.942 (0.745–1.190)	0.614
Killip 3, 4	2.914 (2.328–3.647)	<0.001	1.287 (0.980–1.690)	0.069
Diabetes	1.883 (1.547–2.293)	<0.001	1.350 (1.064–1.711)	0.013
Hypertension	1.852 (1.511–2.269)	<0.001	1.098 (0.854–1.413)	0.465
Previous MI	1.791 (1.297–2.473)	<0.001	1.577 (1.101–2.260)	0.013
LVEF	0.963 (0.955–0.971)	<0.001	0.999 (0.989–1.010)	0.896
Creatinine	1.233 (1.182–1.285)	<0.001	1.115 (1.042–1.192)	0.002
PCI	0.547 (0.429–0.697)	<0.001	0.956 (0.706–1.294)	0.771
Beta blocker	0.560 (0.459–0.683)	<0.001	0.822 (0.655–1.033)	0.093
RAS inhibitor	0.688 (0.551–0.859)	0.001	0.948 (0.723–1.243)	0.699
Statin	0.387 (0.309–0.484)	<0.001	0.717 (0.551–0.934)	0.014
Log (proBNP)	2.772 (2.467 –3.115)	<0.001	1.481 (1.244–1.764)	<0.001
Sinus rhythm	1	NA	1	NA
Paroxysmal AF	2.039 (1.551–2.680)	<0.001	0.993 (0.731–1.349)	0.963
Persistent AF	4.348 (2.767–6.831)	<0.001	1.746 (1.030–2.958)	0.038

AF, atrial fibrillation; BMI, body mass index; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NA, not applicable; PCI, percutaneous coronary intervention; proBNP, pro-brain natriuretic peptide; RAS, renin–angiotensin system; STEMI, ST-segment elevation myocardial infarction.